JOHN S. GOTTDIENER, M.D.; DOUGLAS J. MATHISEN, M.D.; JEFFREY S. BORER, M.D.; ROBERT O. BONOW, M.D.; CHARLES E. MYERS, M.D.; LOUIS H. BARR, M.D.; DAVID E. SCHWARTZ, M.D.; STEPHEN L. BACHARACH, Ph.D.; MICHAEL V. GREEN, M.S.; STEVEN A. ROSENBERG, M.D.
Radionuclide cineangiography was used to evaluate 32 patients who sustained long-term remission of soft tissue sarcoma after adjuvant therapy with a cumulative doxorubicin dose from 480 to 550 mg/m2 body surface area. Left ventricular ejection fraction at rest was below normal (less than 45%) in eight of 32 patients. The abnormal response of ejection fraction to exercise identified an additional 12 patients with diminished left ventricular functional reserve. Ejection fraction determined at rest or during exercise did not differ between patients studied an average of 5 months (range, 1 to 9 months) and those studied 30 months (range, 21 to 43 months) after completing doxorubicin treatment. Sequential studies in 13 patients, done 6 to 15 months after initial post-doxorubicin evaluation also showed persistent depression of average ejection fraction at rest and with exercise, with the continued deterioration of left ventricular function in six patients. Left ventricular dysfunction, evident in over half of asymptomatic patients even long after "acceptable" cumulative doses of doxorubicin, may persist for years.
Learn more about subscription options.
Register Now for a free account.
GOTTDIENER JS, MATHISEN DJ, BORER JS, BONOW RO, MYERS CE, BARR LH, et al. Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide Cineangiography. Ann Intern Med. 1981;94:430–435. doi: 10.7326/0003-4819-94-4-430
Download citation file:
Published: Ann Intern Med. 1981;94(4_Part_1):430-435.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only